P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Abstract Text:

Masaaki Ito,Hiroyuki Nishiyama,Hiroaki Kawanishi,Shigeyuki Matsui,Parry Guilford,Anthony Reeve,Osamu Ogawa,

PURPOSE: It is clinically important to identify bladder cancers with a high risk of intravesical recurrence after transurethral bladder tumor resection. We developed molecular markers for predicting intravesical recurrence of superficial bladder transitional cell carcinoma using oligo-microarray analysis. MATERIALS AND METHODS: Gene expression profiles associated with intravesical recurrence were analyzed by oligo-microarray in 27 superficial bladder transitional cell carcinoma samples from cases treated with transurethral resection between 2000 and 2004 at Kyoto University Hospital. Of candidate genes the expression of P21-activated kinase (Pak1) was validated by semiquantitative real-time polymerase chain reaction using another set of samples and immunohistochemistry. Furthermore, Pak1 functions in bladder cancer cells were analyzed by the transfection of constitutively active (T423E) or kinase dead (K299R) Pak1. RESULTS: Microarray identified 25 genes whose expression was associated with recurrence, including Pak1. Pak1 mRNA expression was statistically associated with grade and the risk of recurrence but not with stage in 86 bladder cancers. Immunohistochemistry and multivariate analysis demonstrated that high Pak1 protein expression was an independent factor associated with recurrence (relative risk 2.27, p = 0.008). High Pak1 expression was significantly associated with a high risk of recurrence even in low stage/grade cancers. Transfection with T423E Pak1 into 253J cells progressed cell motility on wound healing assay, whereas transfection with K299R Pak1 decreased EJ cell motility. CONCLUSIONS: These results suggest that Pak1 expression is associated with recurrence and it might be a useful prognostic marker for superficial bladder transitional cell carcinoma.

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Publishing Authors By Initials

M Ito,H Nishiyama,H Kawanishi,S Matsui,P Guilford,A Reeve,O Ogawa,

For similar enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-serine-threonine kinases: p21-activated kinases research abstracts see: enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-serine-threonine kinases: p21-activated kinases research

PUBMED ID PMID:

MEDLINE DATE:

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The Journal of urology

VOLUME: 178

Page Numbers: 1073-9

Journal Abbreviation: J. Urol.

ISSN: 0022-5347

DAY: 20

MONTH: 07

YEAR: 2007

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376374

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Keywords Mesh Terms:

KEYWORDS: p21-Activated Kinases

MESH TERMS: surgery

Chemical & Substance for Abstract: P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Information

Substance Name: p21-Activated Kinases

Registry Number: EC 2.7.11.1

Grant and Affiliation Information for P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.

AFFILIATION: Department of Urology and Pharmacoepidemiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer Related Publications

• A role for proteoglycans in mineralized tissue-titanium adhesion.
• A simple and rapid method for cryopreservation of mouse 2-cell embryos by vitrification: Beneficial effect of sucrose and raffinose on their cryosurvival rate.
• Accumulation and fate of green fluorescent labeled Escherichia coli in laboratory-scale drinking water biofilters.
• An efficient method for sonication assisted Agrobacterium-mediated transformation of coat protein (CP) coding genes into papaya (Carica papaya L.).
• An fMRI study of the functional distinction of neuronal circuits at the sites on ventral visual stream co-activated by visual stimuli of different objects.
• Cardiac cell therapy and arrhythmias.
• Changing concepts of bladder regeneration.
• Detection and identification of Brettanomyces/Dekkera sp. yeasts with a loop-mediated isothermal amplification method.
• Do children with tuberous sclerosis complex have superior musical skill?--A unique tendency of musical responsiveness in children with TSC.
• From gene networks underlying sex determination and gonadal differentiation to the development of neural networks regulating sociosexual behavior.
• Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.
• Glycosaminoglycan degradation reduces mineralized tissue-titanium interfacial strength.
• Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties.
• Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis.
• Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.
• Impacts of diclidophorid monogenean infections on fisheries in Japan.
• Incorporating electron-transfer functionality into synthetic metalloproteins from the bottom-up.
• Interaction between p21-activated protein kinase and Rac during differentiation of HL-60 human promyelocytic leukemia cell induced by all-trans-retinoic acid.
• Meiotic recombination-related DNA synthesis and its implications for cross-over and non-cross-over recombinant formation.
• Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates.
• Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats.
• P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
• Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
• Production of functional spermatids from mouse germline stem cells in ectopically reconstituted seminiferous tubules.
• Production of normal piglets from microsurgically split morulae and blastocysts.
• Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome.
• Solitary upper ureteral malakoplakia successfully diagnosed by ureteroscopic biopsy and treated conservatively.
• Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
• The survival of whole and bisected rabbit morulae after cryopreservation by the vitrification method.
• Ventricular septal rupture masquerading as coronary perforation during intervention for acute myocardial infarction.